Abstract Information 2017-10-12T18:10:13+00:00

Abstract Submission Information

Awards

Financial Need Award

  1. FINANCIAL NEED AWARD -Registrants from a low-resource country who have an abstract accepted may apply for merit Award (registration fee waiver). A letter by email detailing reasons for financial need must be attached with the abstract submission (limit- 10 financial need awards).

Best Abstract Awards

  1. Best oral abstracts will be selected by scientific merit for oral presentation in each plenary session of the meeting. An award of $1000 (us) will be made for the best oral presentation at the meeting.
  2. Eighteen abstracts of noteworthy scientific merit will be selected for a poster discussion session at the meeting. An award of $1000 (us) will be made for the best poster discussion presentation at the meeting.
  3. Additionally, other accepted abstracts will be presented in the general poster session. An award of $1000 (us) will be made for the best poster in the general session at the meeting.

Abstract format

  1. Abstracts must be submitted via e-mail as a Microsoft Word document attachment;  Abstract should not exceed 400 words including title and body (authors’ names and institutions are not counted). (limit to one figure or one table are also not counted).
  2. Use 10 pt. Times font.
  3. Abstract format is as follows:
  • Title (title case)
  • Authors, institution, city, state or province, country
  • Body (use the following headings):
  • Background
  • Objectives
  • Design/methods
  • Results
  • Conclusion

    The following information must be included in the e-mail with each submission:

  1. Name of corresponding author
  2. Department/institution, city, country
  3. Telephone number
  4. E-mail address of corresponding author

 

Category Desired

1-B-cell non-hodgkin lymphoma 7-Novel Therapeutics
2-Aya Non-Hodgkin and Hodgkin Lymphoma 8-Lymphoblastic Lymphoma
3-T and NK Non-Hodgkin Lymphoma 9-Relapsed/Refractory NHL
4-Lymphoma Immunology, BMT & Cell Therapy 10-Late Effects / Survivorship of NHL
5-Anaplastic Large Cell Lymphoma 11-Hodgkin Lymphoma
6-Lymphoma Translational Biology 12-NHL in Low Resourced Countries
(authors must indicate the one scientific category)

Abstracts pertinent to childhood, adolescent and young adult Non-Hodgkin and Hodgkin Lymphoma that have been accepted/presented at scientific meetings within the past 18 months are also acceptable for submission to this symposium.

Abstract Review:

    1. Abstracts will be peer-reviewed according to scientific categories.
    2. Notification of acceptance or rejection of abstracts will be made via e-mail on or around June 11th, 2018.
    3. The decision of the reviewing committees regarding the acceptance of abstracts is final.
Abstract Submission Form

Abstract Deadline- Monday, May 7, 2018, 5:00pm EST

  • Abstracts must be received by Monday, May 7th, 2018, 5:00 pm est, to be considered for presentation.
  • Abstracts must address scientific questions pertaining to childhood, adolescent, or young adult Non-Hodgkins lymphoma or Hodgkin Lymphoma.
  • Abstracts will be published in British Journal of Haematology.
  • Abstracts are to be submitted via E-mail as a Microsoft Word document attachment.
Abstract Submission Form
For more information please contactMiguel Muniz
nhl_symposium@nymc.edu